Plain-English translation of NCT07480356 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it works better than standard chemotherapy for treating a specific type of bladder cancer called high-grade non-muscle invasive bladder cancer. The study will enroll about 284 patients and compare how well this medication works, how safe it is, and what side effects people experience compared to standard chemotherapy.
Currently, doctors use standard chemotherapy delivered directly into the bladder to treat this type of cancer. Researchers want to know if this new treatment could be more effective or have fewer side effects than what patients receive today.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either or standard chemotherapy delivered directly into your bladder through a catheter. You would attend study visits where researchers monitor how well the treatment is working, check for side effects, and perform tests. The exact schedule and duration would be explained by the research team, but typically these treatments involve regular bladder instillations (medication placed directly in the bladder) over several weeks or months.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
United States